Elisa Heyrman

About me

I am a postdoctoral researcher in the division Clinical Physiology, Department Laboratory Medicin located at KI campus Flemingsberg.

My research focuses on immune cell characterisation of cancer and long covid patients who participated in exercise interventions.

I am part of the PREFERABLE consortium which established a multi-national clinical trial for cancer patients, studying the effect of exercise on their quality of life, as well as biological outcomes. The PREFERABLE study focuses on breast cancer patients and the assessment of fatigue and quality of life during and after a supervised 9-month exercise intervention. https://www.h2020preferable.eu/

Personal interests: exercise physiology, prevention and early detection of cancer, liquid biopsies using extracellular vesicles

Journal article: NATURE COMMUNICATIONS. 2019;10(1):3288

The generation and use of recombinant extracellular vesicles as biological reference material.

Geeurickx E; Tulkens J; Dhondt B; Van Deun J; Lippens L; Vergauwen G; Heyrman E; De Sutter D; Gevaert K; Impens F; Miinalainen I; Van Bockstal P-J; De Beer T; Wauben MHM; Nolte-'t-Hoen ENM; Bloch K; Swinnen JV; van der Pol E; Nieuwland R; Braems G; Callewaert N; Mestdagh P; Vandesompele J; Denys H; Eyckerman S; De Wever O; Hendrix A

Postdoctoral Researcher, Department of Laboratory Medicine, Karolinska Institutet, 2023-2025

PhD, Oncolytic virotherapy, Development of a recombinant oncolytic Vaccinia virus encoding a SIRPα-Fc fusion protein to enhance innate antitumour immunity, Queen Mary University of London, 2023
MSc in Biomedical Science, Major cancer, Development and evaluation of a traceable reference material for extracellular vesicles in liquid biopsies, Ghent University, 2018
BSc in Biomedical Science, Biomedical Science, Ghent University, 2016